Dr. Michael Pellini has served on our board of directors since February 2018. Mike currently serves as a Managing Partner of Section 32, LLC, a technology and life sciences-based venture capital fund. Mike currently serves as a member of the board of directors of the Personalized Medicine Coalition and the Mission Hospital Foundation and several private companies. Mike previously served as chairman of the board of directors, Chief Executive Officer and President at Foundation Medicine, Inc., a molecular information company, which was acquired by F. Hoffmann-La Roche Ltd. in 2018. Mike holds an MD from Jefferson Medical College, an MBA from Drexel University and a BA in Economics from Boston College.